Is Fate Therapeutics, Inc. (FATE) a Buy, Sell, or Hold?
NASDAQ : FATE
Fate Therapeutics, Inc.
$2.99 USD
$0 (0.0%)
- Volume
- 1.93M
- Average Volume
- 4.09M
- Market Capitalization
- $348.51M
- P/E Ratio
- -2.74
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $3.23
- Year Low
- $0.91
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.85
FATE vs. The Competition
| Properties | FATE | ABOS | ALEC | CRBP |
|---|---|---|---|---|
| Market Cap | $348.51M | $134.47M | $166.54M | $112.94M |
| Shares Outstanding | $116.56M | $60.57M | $111.02M | $12.54M |
| P/E Ratio | -2.74 | -1.19 | -1.26 | -1.37 |
| EPS | -1.08 | -1.79 | -1.13 | -6.35 |
| Day Low | 2.86 | 2.205 | 1.37 | 8.8 |
| Day high | 3.015 | 2.54 | 1.53 | 9.1599 |
| Year Low | 0.91 | 1.19 | 1.09 | 7.12 |
| Year High | 3.23 | 3.6 | 3.4 | 20.56 |
| Average Price 50 | 2.3248 | 2.437 | 1.9313 | 9.1437 |
| Average Price 200 | 1.49595 | 2.33228 | 1.97705 | 10.1005 |
| Volume | 1.93M | 674.38K | 718.78K | 272.56K |
| Average Volume | - | - | - | - |